Thus, a reduced abundance of tumor-associated M2 macrophages following DPN treatment relates to the “negative regulation of inflammatory response” and the “response to TGFβ” in the TME of the Granta-159 tumors, as determined by the GO BP analysis. The gene discussed is TGFB1; the disease is neoplasm.